Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serena Ricciardi

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Current Opinion in Oncology|December 17, 2009
Multimodality management of non-small cell lung cancer patients with brain metastasesSerena Ricciardi, Filippo de Marinis
Oncology|February 5, 2010
New agents in advanced non-small-cell lung cancer treatmentSerena Ricciardi, Filippo de Marinis
Reviews on Recent Clinical Trials|December 24, 2009
Treatment of bone metastases in lung cancer: the actual role of zoledronic acidSerena Ricciardi, Filippo de Marinis
Tumori|December 31, 2008
[Role of pemetrexed in the treatment of advanced non-small-cell lung cancer: news from ASCO, 2008]Filippo de Marinis, Serena Ricciardi
European Journal of Cancer (Oxford, England : 1990)|September 28, 2011
Second-line treatment options in advanced non-small cell lung cancerFilippo de Marinis, Serena Ricciardi
Future Oncology (London, England)|July 11, 2018
New options on the horizon for nononcogene addicted non-small-cell lung cancerLuca Paglialunga, Serena Ricciardi, Manolo D'Arcangelo
Clinical Lung Cancer|March 18, 2009
Toxicity of targeted therapy in non-small-cell lung cancer managementSerena Ricciardi, Silverio Tomao, Filippo de Marinis
Lung Cancer (Auckland, N.Z.)|February 18, 2017
Efficacy and safety of erlotinib in the treatment of metastatic non-small-cell lung cancerSerena Ricciardi, Silverio Tomao, Filippo de Marinis
Therapeutics and Clinical Risk Management|October 24, 2009
Pemetrexed as first-line therapy for non-squamous non-small cell lung cancerSerena Ricciardi, Silverio Tomao, Filippo de Marinis
Lung Cancer (Amsterdam, Netherlands)|July 7, 2009
Pemetrexed in the treatment of advanced non-squamous lung cancerAntonio Rossi, Serena Ricciardi, Paolo Maione, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Current Opinion in Oncology|December 17, 2009
Multimodality management of non-small cell lung cancer patients with brain metastasesSerena Ricciardi, Filippo de Marinis
Oncology|February 5, 2010
New agents in advanced non-small-cell lung cancer treatmentSerena Ricciardi, Filippo de Marinis
Reviews on Recent Clinical Trials|December 24, 2009
Treatment of bone metastases in lung cancer: the actual role of zoledronic acidSerena Ricciardi, Filippo de Marinis
Tumori|December 31, 2008
[Role of pemetrexed in the treatment of advanced non-small-cell lung cancer: news from ASCO, 2008]Filippo de Marinis, Serena Ricciardi
European Journal of Cancer (Oxford, England : 1990)|September 28, 2011
Second-line treatment options in advanced non-small cell lung cancerFilippo de Marinis, Serena Ricciardi
Future Oncology (London, England)|July 11, 2018
New options on the horizon for nononcogene addicted non-small-cell lung cancerLuca Paglialunga, Serena Ricciardi, Manolo D'Arcangelo
Clinical Lung Cancer|March 18, 2009
Toxicity of targeted therapy in non-small-cell lung cancer managementSerena Ricciardi, Silverio Tomao, Filippo de Marinis
Lung Cancer (Auckland, N.Z.)|February 18, 2017
Efficacy and safety of erlotinib in the treatment of metastatic non-small-cell lung cancerSerena Ricciardi, Silverio Tomao, Filippo de Marinis
Therapeutics and Clinical Risk Management|October 24, 2009
Pemetrexed as first-line therapy for non-squamous non-small cell lung cancerSerena Ricciardi, Silverio Tomao, Filippo de Marinis
Lung Cancer (Amsterdam, Netherlands)|July 7, 2009
Pemetrexed in the treatment of advanced non-squamous lung cancerAntonio Rossi, Serena Ricciardi, Paolo Maione, et al.
Pageof 6